Why the Reva Medical share price is up 20% today

The Reva Medical Inc (ASX: RVA) share price is up 20% or 4 cents to 24 cents today after the US-based medical device hopeful yesterday reported that it has expanded into seven new European countries “with the addition of four new distribution partnerships”.

The company reports it is “focused on the development and commercialisation of bioresorbable polymer technologies for vascular applications”, with products including the Fantom Encore and “MOTIV bioresorbable vascular scaffolds for the treatment of coronary artery disease and below-the-knee peripheral artery disease.”

For the quarter ending September 30 2018 Reva posted an operating cash loss and has a market value around A$83 million according to Commsec. Reva also reports that it’s considering a US stock market listing in 2019.

It claims to have plans to become a $1 billion plus company, but for now its cash flows are negative and its share price is unsurprisingly volatile.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!